From Nov 4 to 6, Lei Ping, deputy commissioner of the National Medical Products Administration (NMPA), led a delegation to attend the 9th China International Import Expo (CIIE) in Shanghai.

Lei attended the opening ceremony of the CIIE and spoke at the "International Drug Safety Governance and China's Drug Regulatory Reform" parallel session of the 9th Hongqiao International Economic Forum, co-hosted by the NMPA and the Secretariat of the Hongqiao Forum.

Lei said that the global pharmaceutical industrial chain and innovation chain are now deeply intertwined. The NMPA is committed to striking the balance between development and security, between quality and efficiency as well as between regulation and services, and to building a world-class regulatory environment and innovation ecosystem so that China remains a vibrant hub for global pharmaceutical innovation, he noted.

He welcomed pharmaceutical companies from around the world to bring their latest innovations to China at the earliest opportunity for the benefit of Chinese people, and pledged full support for high-quality Chinese drugs and medical devices to reach global markets and benefit patients worldwide.

International guests, heads of industry associations, global heads of multinational corporations and officials from relevant departments and affiliated institutions of the NMPA were present at the parallel session and gave thematic presentations.